Company page

Akebia Therapeutics, Inc.

Akebia Therapeutics, Inc. (Ticker: AKBA) is a public company based in the United States, with a market capitalization of approximately $327.3 million. The company focuses on developing and commercializing innovative therapies for patients with kidney disease. Akebia is committed to addressing unmet medical needs in this area through its research and development efforts.